Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease

Journal of Psychiatric Research

Volumn 47, Issue 5, 2013, Pages 644-649

  Wang, Rui tao ^a   Jin, Di ^a   Li, Ying ^a   Liang, Qing cheng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Cognitive function; Mean platelet volume; Mild cognitive impairment; Platelet distribution width

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

EID: 84875236148     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.01.014     Document Type: Article

References (48)

1. Agostinho P., Cunha R.A., Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Current Pharmaceutical Design 2010, 16:2766-2778.
2. Bentham P., Gray R., Sellwood E., Hills R., Crome P., Raftery J. Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial. Lancet Neurology 2008, 7:41-49.
3. Berger J.S., Eraso L.H., Xie D., Sha D., Mohler E.R. Mean platelet volume and prevalence of peripheral artery disease, the national health and nutrition examination survey, 1999-2004. Atherosclerosis 2010, 213:586-591.
4. Bermejo P., Martin-Aragon S., Benedi J., Susin C., Felici E., Gil P., et al. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunology Letters 2008, 117:198-202.
5. Boos C.J., Beevers G.D., Lip G.Y. Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension. Annals of Medicine 2007, 39:72-78.
6. Borroni B., Agosti C., Marcello E., Di L.M., Padovani A. Blood cell markers in Alzheimer disease: amyloid precursor protein form ratio in platelets. Experimental Gerontology 2010, 45:53-56.
7. Bush A.I., Martins R.N., Rumble B., Moir R., Fuller S., Milward E., et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. Journal of Biological Chemistry 1990, 265:15977-15983.
8. Chu S.G., Becker R.C., Berger P.B., Bhatt D.L., Eikelboom J.W., Konkle B., et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis 2010, 8:148-156.
9. Coban E., Afacan B. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment. Platelets 2008, 19:111-114.
10. Evin G., Zhu A., Holsinger R.M., Masters C.L., Li Q.X. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. Journal of Neuroscience Research 2003, 74:386-392.
11. Forlenza O.V., Torres C.A., Talib L.L., de Paula V.J., Joaquim H.P., Diniz B.S., et al. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. Journal of Psychiatric Research 2011, 45:220-224.
12. Forlenza O.V., Wacker P., Nunes P.V., Yacubian J., Castro C.C., Otaduy M.C., et al. Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study. Psychopharmacology (Berlin) 2005, 180:359-365.
13. Gasparyan A.Y., Ayvazyan L., Mikhailidis D.P., Kitas G.D. Mean platelet volume: a link between thrombosis and inflammation. Current Pharmaceutical Design 2011, 17:47-58.
14. Gomez R.M., Moscato P. Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease. PLoS One 2008, 3:e3111.
15. Hachinski V., Iadecola C., Petersen R.C., Breteler M.M., Nyenhuis D.L., Black S.E., et al. National Institute of Neurological Disorders and Stroke - Canadian stroke network vascular cognitive impairment harmonization standards. Stroke 2006, 37:2220-2241.
16. Horstman L.L., Jy W., Ahn Y.S., Zivadinov R., Maghzi A.H., Etemadifar M., et al. Role of platelets in neuroinflammation: a wide-angle perspective. Journal of Neuroinflammation 2010, 7:10.
17. Iarlori C., Gambi D., Gambi F., Lucci I., Feliciani C., Salvatore M., et al. Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease. Experimental Gerontology 2005, 40:605-611.
18. Jagroop I.A., Mikhailidis D.P. Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. Journal of Human Hypertension 2000, 14:581-585.
19. Jaremo P., Milovanovic M., Buller C., Nilsson S., Winblad B. Low-density platelet populations demonstrate low in vivo activity in sporadic Alzheimer disease. Platelets 2012, 23:116-120.
20. Johnston J.A., Liu W.W., Coulson D.T., Todd S., Murphy S., Brennan S., et al. Platelet beta-secretase activity is increased in Alzheimer's disease. Neurobiology of Aging 2008, 29:661-668.
21. Kaito K., Otsubo H., Usui N., Yoshida M., Tanno J., Kurihara E., et al. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. British Journal of Haematology 2005, 128:698-702.
22. Kapsoritakis A.N., Koukourakis M.I., Sfiridaki A., Potamianos S.P., Kosmadaki M.G., Koutroubakis I.E., et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. American Journal of Gastroenterology 2001, 96:776-781.
23. Kaushansky K. Thrombopoietin. New England Journal of Medicine 1998, 339:746-754.
24. Krzystanek E., Krzystanek M., Opala G., Trzeciak H.I., Siuda J., Malecki A. Platelet phospholipase A2 activity in patients with Alzheimer's disease, vascular dementia and ischemic stroke. Journal of Neural Transmission 2007, 114:1033-1039.
25. Lampron A., Gosselin D., Rivest S. Targeting the hematopoietic system for the treatment of Alzheimer's disease. Brain, Behavior, and Immunity 2011, 25(Suppl. 1):S71-S79.
26. Laske C., Leyhe T., Stransky E., Eschweiler G.W., Bueltmann A., Langer H., et al. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease. Journal of Psychiatric Research 2008, 42:746-751.
27. Lee J.K., Jin H.K., Bae J.S. Bone marrow-derived mesenchymal stem cells attenuate amyloid beta-induced memory impairment and apoptosis by inhibiting neuronal cell death. Current Alzheimer Research 2010, 7:540-548.
28. Lee J.K., Jin H.K., Endo S., Schuchman E.H., Carter J.E., Bae J.S. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 2010, 28:329-343.
29. Li Q.X., Berndt M.C., Bush A.I., Rumble B., Mackenzie I., Friedhuber A., et al. Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. Blood 1994, 84:133-142.
30. Li Q.X., Whyte S., Tanner J.E., Evin G., Beyreuther K., Masters C.L. Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets. Laboratory Investigation 1998, 78:461-469.
31. Matsagas M., Jagroop I.A., Geroulakos G., Mikhailidis D.P. The effect of a loading dose (300 mg) of clopidogrel on platelet function in patients with peripheral arterial disease. Clinical and Applied Thrombosis/Hemostasis 2003, 9:115-120.
32. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432.
33. Mukaetova-Ladinska E.B., Abdel-All Z., Dodds S., Andrade J., Alves d.S.J., Kalaria R.N., et al. Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study. Age and Ageing 2012, 41:408-412.
34. Muscari A., Puddu G.M., Cenni A., Silvestri M.G., Giuzio R., Rosati M., et al. Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes. Thrombosis Research 2009, 123:587-591.
35. Nielsen H.M., Londos E., Minthon L., Janciauskiene S.M. Soluble adhesion molecules and angiotensin-converting enzyme in dementia. Neurobiology of Disease 2007, 26:27-35.
36. Ntaios G., Gurer O., Faouzi M., Aubert C., Michel P. Hypertension is an independent predictor of mean platelet volume in patients with acute ischaemic stroke. Internal Medicine Journal 2011, 41:691-695.
37. Papanas N., Symeonidis G., Maltezos E., Mavridis G., Karavageli E., Vosnakidis T., et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004, 15:475-478.
38. Prodan C.I., Ross E.D., Stoner J.A., Cowan L.D., Vincent A.S., Dale G.L. Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology 2011, 76:247-252.
39. Skovronsky D.M., Lee V.M., Pratico D. Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C. Journal of Biological Chemistry 2001, 276:17036-17043.
40. Stellos K., Panagiota V., Kogel A., Leyhe T., Gawaz M., Laske C. Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients. Journal of Cerebral Blood Flow & Metabolism 2010, 30:1817-1820.
41. Thompson C.B., Love D.G., Quinn P.G., Valeri C.R. Platelet size does not correlate with platelet age. Blood 1983, 62:487-494.
42. Thoonsen H., Richard E., Bentham P., Gray R., van G.N., De Haan R.J., et al. Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern. Stroke 2010, 41:2690-2692.
43. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 2004, 256:240-246.
44. Wulan S.N., Westerterp K.R., Plasqui G. Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Maturitas 2010, 65:315-319.
45. Yazici S., Yazici M., Erer B., Erer B., Calik Y., Ozhan H., et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 2010, 21:122-125.
46. Yesil Y., Kuyumcu M.E., Cankurtaran M., Uz B., Kara A., Kilic M.K., et al. Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD). Archives of Gerontology and Geriatrics 2012, 55:257-260.
47. Yuksel O., Helvaci K., Basar O., Koklu S., Caner S., Helvaci N., et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets 2009, 20:277-281.
48. Zheng W., McLerran D.F., Rolland B., Zhang X., Inoue M., Matsuo K., et al. Association between body-mass index and risk of death in more than 1 million Asians. New England Journal of Medicine 2011, 364:719-729.